RESPIRATORY RESPONSE AND PHARMACOKINETICS OF INTRAVENOUS SALBUTAMOL IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA

被引:19
作者
KIRPALANI, H
KOREN, G
SCHMIDT, B
TAN, Y
SANTOS, R
SOLDIN, S
机构
[1] HOSP SICK CHILDREN,DIV CLIN PHARMACOL,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA
[2] HOSP SICK CHILDREN,DIV NEONATOL,TORONTO M5G 1X8,ONTARIO,CANADA
[3] HOSP SICK CHILDREN,DIV RESP THERAPY,TORONTO M5G 1X8,ONTARIO,CANADA
[4] HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA
[5] HOSP SICK CHILDREN,DEPT BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA
[6] HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA
关键词
D O I
10.1097/00003246-199012000-00013
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The effects of iv salbutamol on respiratory mechanics were studied in six infants with bronchopulmonary dysplasia. Salbutamol was infused at a dose of 30 μg/kg over 30 min in five infants; a sixth infant received 66.7 μg/kg over 4 min. Salbutamol caused improvement in total respiratory system compliance and in airflow resistance. There was no correlation between salbutamol serum concentration and pulmonary function. Elimination half-time appears to be dictated in these infants more by the distribution volume (V(d)) than by clearance (C1). The area under concentration-time curve of salbutamol correlated inversely to the change in heart rate (HR). There was a significant positive correlation between V(d) and percent HR change. These data provide evidence that preterm infants have measurable activity of bronchiolar β2 receptor responsive to salbutamol.
引用
收藏
页码:1374 / 1377
页数:4
相关论文
共 15 条